Temozolomide Global Buyers List: Top Importers, Market Share & Sourcing Intelligence
Temozolomide — the oral alkylating agent that has become a cornerstone in the treatment of glioblastoma multiforme and other aggressive brain tumors — commands a robust and growing global pharmaceutical market. With the global temozolomide market estimated at USD 1.44 billion in 2026 and projected to reach USD 2.44 billion by 2033 at a CAGR of 7.8%, understanding who buys temozolomide, where they are located, and how the supply chain operates is essential for manufacturers, distributors, and procurement professionals alike.
This comprehensive guide delivers a verified temozolomide global buyers list based on Indian Customs (DGFT) data, covering 250+ active importers across 90+ countries, with detailed market share analysis, top buyer profiles, and strategic sourcing intelligence.
Global Temozolomide Market at a Glance
Before diving into the buyer list, it is important to understand the scale of the market. India accounts for a significant share of global temozolomide exports, with 133+ registered manufacturers shipping to buyers across 90+ countries. The total temozolomide export value from India stands at $23.5 million across 1,261 shipments, serving 250 active buyers.
The market is characterized by a relatively concentrated supply base — the top two suppliers alone account for 45.3% of all exports — yet the buyer network is broad and globally distributed, spanning pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Top Temozolomide Buyers & Importers — Ranked by Import Value
Based on verified Indian Customs (DGFT) shipping bill records, the following table presents the leading temozolomide buyers globally:
| Rank | Buyer Name | Country | Import Value | Market Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $4.7M | 19.9% |
| 2 | TARO PHARMACEUTICALS INC. | CANADA | $3.0M | 12.9% |
| 3 | TARO PHARMACEUTICALS INC | CANADA | $2.7M | 11.5% |
| 4 | OOO”JODAS EXPOIM” | RUSSIA | $1.1M | 4.5% |
| 5 | M/S. SUN FARMACEUTICA DO BRAZIL LTD | BRAZIL | — | — |
The top 5 buyers collectively control 53.0% of total import value, reflecting a moderately competitive buyer landscape where a handful of large importers dominate procurement.
Buyer Profiles: Who Are the Top Temozolomide Importers?
1. YUSEN LOGISTICS BENELUX BELGIUM — The Market Leader
YUSEN LOGISTICS BENELUX BELGIUM ranks as the #1 importer of temozolomide from India, holding a commanding 19.9% market share. With $4.3 million in import value across 207 verified shipments, this Belgium-based logistics and pharmaceutical distribution company sources exclusively from SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Key formulations imported include Temozolomide SUN Capsules in 100mg, 140mg, and 250mg strengths. The average shipment value stands at $25.4K, and the company imports to Belgium as the sole destination country.
2. TARO PHARMACEUTICALS INC. — Canada’s Largest Buyer
TARO PHARMACEUTICALS INC. is the #2 importer, with $3.0 million in import value across multiple shipments. The Canadian pharmaceutical company holds a 12.9% market share and sources exclusively from SUN PHARMACEUTICAL INDUSTRIES LIMITED.
The company imports Taro-Temozolomide capsules in 100mg and 140mg strengths. With an average shipment value of $50.0K — notably higher than the market average of $38.6K — TARO PHARMACEUTICALS INC. represents a premium-volume buyer in the Canadian market.
3. OOO”JODAS EXPOIM” — Russia’s Primary Importer
Ranked #4 among global buyers, OOO”JODAS EXPOIM” from Russia imports temozolomide valued at $1.1 million, holding a 4.5% market share. The company sources temozolomide lyophilisate for preparation and capsules in 100mg strength.
4. M/S. SUN FARMACEUTICA DO BRAZIL LTD — Brazil’s Leading Buyer
Completing the top 5, M/S. SUN FARMACEUTICA DO BRAZIL LTD serves as a key distribution hub for temozolomide in the Brazilian pharmaceutical market, importing Taro-Temozolomide 100mg capsules.
Temozolomide Buyers by Region
North America
Canada stands out as a major destination for Indian temozolomide exports. India exported $7.5 million worth of temozolomide to Canada between 2022 and 2026, with 5 manufacturers supplying 11 Canadian buyers. TARO PHARMACEUTICALS INC. is the largest importer in Canada with $3.0 million in purchases. Other notable Canadian buyers include JAMP PHARMA CORP.
The United States imports temozolomide from 9 Indian manufacturers, serving 15 U.S. buyers. Key U.S. importers include RISING PHARMA HOLDINGS, INC., SUN PHARMACEUTICAL INDUSTRIES INC., and EVERSANA LIFE SCIENCES SERVICES, LLC.
Europe
Belgium is the single largest destination for Indian temozolomide exports, accounting for 57.2% of SUN Pharmaceutical Industries Limited’s shipments. YUSEN LOGISTICS BENELUX BELGIUM and YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN together represent over $5.2 million in imports.
Other European buyers include:
- PHARMACENTER HUNGARY LTD (Hungary) — $255.7K
- ACCORD HEALTHCARE B V (Netherlands) — $118.4K
- ACCORD HEALTHCARE POLSKA SP Z O O (Poland) — $62.8K
- ACCORD HEALTHCARE SLU (Spain) — $16.1K
Asia-Pacific
Key Asian buyers include:
- ALLIANCE PHARMA CO., LTD. (Thailand) — $131.0K
- DELTA IMPORT-EXPORT MEDICAL CO., LTD. (Vietnam)
- ASAHI KASEI FINECHEM CO., LTD. (Japan)
- EUGIA PHARMA SPECIALITIES LIMITED (India)
Other Regions
Russia remains a significant market, with OOO”JODAS EXPOIM” and related entities importing substantial volumes. Turkey’s DEM PHARMACEUTICALS ranks among the top 10 importers with $471.2K. Buyers in South Africa, Morocco, and Sri Lanka also feature in the global buyer network.
Top Temozolomide Suppliers & Their Buyer Networks
Understanding the supply side is equally important for buyers seeking reliable sourcing partners.
SUN Pharmaceutical Industries Limited — The Dominant Supplier
SUN Pharmaceutical Industries Limited is the #1 Indian exporter of temozolomide, with $15.6 million in export value and 311 verified shipments, holding a 62.4% market share. The company exports to 8 countries and supplies 28 buyers globally.
Top buyers of SUN Pharmaceutical Industries Limited:
| Buyer | Country | Value |
|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $3.8M |
| TARO PHARMACEUTICALS INC. | CANADA | $590.9K |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $493.4K |
| TARO PHARMACEUTICALS INC | CANADA | $420.0K |
| LABORATORIOS LA SANTE S.A. | COLOMBIA | $256.5K |
Other Major Suppliers
- SUN Pharmaceutical Industries Ltd — #2 exporter, $950.0K
- Jodas Expoim Private Limited — #3 exporter, $1.8M
- Reliance Life Sciences Private Limited — #4 exporter, $1.1M
- Intas Pharmaceuticals Limited — #7 exporter, $500.0K
Intas Pharmaceuticals Limited supplies temozolomide to 14 buyers globally, with top buyers including ALLIANCE PHARMA CO., LTD. (Thailand, $131.0K) and EVERSANA LIFE SCIENCES SERVICES, LLC (United States, $130.9K).
Temozolomide API Manufacturers & Regulatory Landscape
For buyers seeking direct API sourcing, the temozolomide API manufacturing landscape is well-regulated. According to PharmaDB data, there are 14 manufacturers with active filings, 12 of whom hold a US DMF or a CEP. The median export price per kilogram is $3,492.93, ranging from $2,381.44 to $5,998.58.
Notable API manufacturers include:
- Shilpa Medicare Ltd. — holds active US DMF and valid CEP, 2025 FDA inspection closed as NAI, GMP recognized in 23 markets
- Cipla — holds US DMF
- Hetero Drugs — holds US DMF
- Suzhou Lixin Pharmaceutical CO., LTD. — API manufacturer
- Shivalik Rasayan Ltd. — API manufacturer
Buyers should note that finished-dose manufacturers number 305 across 45 regulators, with 128 shortage records on file across 3 countries.
How to Use This Temozolomide Buyers List for Your Sourcing Strategy
For Suppliers and Exporters
- Target high-volume buyers: YUSEN LOGISTICS BENELUX BELGIUM and TARO PHARMACEUTICALS INC. represent the largest procurement opportunities. Understanding their formulation requirements (100mg, 140mg, 250mg capsules) is essential.
- Expand into emerging markets: Countries like Vietnam, Turkey, and Morocco show growing import activity.
- Leverage regulatory credentials: Buyers increasingly prioritize suppliers with US DMF, CEP, and WHO-GMP certifications.
For Buyers and Procurement Professionals
- Diversify supplier base: While SUN Pharmaceutical dominates, alternative suppliers like Jodas Expoim, Reliance Life Sciences, and Intas Pharmaceuticals offer competitive sourcing options.
- Understand market pricing: With API prices ranging from $2,381 to $5,998 per kg, buyers should benchmark pricing against verified trade data.
- Monitor regulatory status: FDA inspection outcomes (NAI, VAI) and GMP recognition across markets are critical due diligence factors.
Market Outlook: What’s Driving Temozolomide Demand?
The temozolomide market is poised for sustained growth, driven by:
- Rising glioblastoma incidence: The expanding evidence base has reinforced temozolomide’s role as a cornerstone in glioblastoma multiforme treatment
- Generic market expansion: Major generic players including Teva, Dr. Reddy’s, Aurobindo Pharma, Cipla, Lupin, and Sandoz are active in the space
- New formulations: Innovations like oral suspensions (e.g., Kimozo 40mg/ml) are expanding the addressable market
- Global oncology infrastructure growth: North America, Europe, Asia, and Latin America remain important treatment markets
CAMBER PHARMACEUTICALS INC
CHROMACHEMIE LABORATORY PRIVATE LIMITED
MERCK SHARP DOHME I A LLC
GADOR S A
MSD ARGENTINA S R L
SIGMA ALDRICH CHEMICALS PRIVATE LIMITED
LABORATORIOS EUROMED CHILE S A
MINISTERIO DE SALUD
MERIXIL PHARMA
TECNOFARMA S A
LABORATORIOS PHOENIX SAIC Y F
MARTIN DOW LIMITED
MERCK SHARP AND DOHME COLOMBIA S A S
SEVEN PHARMA CHILE SPA
SUN PHARMA CANADA INC
PT AMAROX PHARMA GLOBAL
CÔNG TY TNHH XUẤT NHẬP KHẨU Y TẾ DELTA
OPKO CHILE S A
TOKYO CHEMICAL INDUSTRY INDIA PRIVATE LIMITED
EUGIA PHARMA SPECIALITIES LIMITED
MERCK SHARP DOHME PERU S R L
CÔNG TY TNHH MSD HH VIỆT NAM
JODAS EXPOIM PRIVATE LIMITED
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORYPRIVATE LI
SUN PHARMACEUTICAL INDUSTRIES LIMITED
INTAS PHARMACEUTICALS LIMITED
LABORATORIOS LA SANTE SA
MERCK SHARP DOHME COMERCIALIZADORA S DE RL DE CV
SCHMIDTS PHARMA S R L
SOPHARMA S R L
TARGET SA
ADIUM PHARMA S A
MERCK LIFE SCIENCE PRIVATE LIMITED
SUN PHARMACEUTICAL INDUSTRIES INC
UNITED STATES PHARMACOPEIA INDIA PRIVATE LIMITED
CONEPRE SA DE CV
EXPEDITORS INTL OF WA INC
MEDSCRIBE LIMITED
NOVARTIS ARGENTINA S A
AMAROX PHARMA SA DE CV
AMB HK ENTERPRISES INC
APOTEX S A
ECZANE PHARMA LABORATORIOS ECZANEPHARMA SA
EUROFARMA ARGENTINA S A
LABORATORIOS IMA S A I C
PHARMASOL PRIVATE LTD
SIGMA ALDRICH QUIMICA S DE RL DE CV
YUSEN LOGISTICS BENELUX BV
BIOTENG S A
CÔNG TY TNHH DƯỢC PHẨM VÀ TRANG THIẾT BỊ Y TẾ HOÀNG ĐỨC
EUGIA PHARMA COLOMBIA SAS
GEKA PHARMA PTY LTD
LABORATORIO LIBRA SOCIEDAD ANONIMA
ONCOPHARM U LTD
SEVEN PHARMA DEL ECUADOR DISTRIBUIDORA COMERCIALIZADORA SEVENPHARMA S A
SIGMA ALDRICH QUIMICA LIMITADA
2MG INCORPORATED
CÔNG TY TNHH DƯỢC PHẨM VÀ HÓA CHẤT NAM LINH
EUROFARMA PERU S A C
EXPEDITORS INTL OF WASHINGTON INC
XINETIX PHARMA S A S
ASOCIACION VIDA PERU
CÔNG TY CỔ PHẦN DƯỢC TRANG THIẾT BỊ Y TẾ BÌNH ĐỊNH BIDIPHAR
CÔNG TY TNHH MTV NOVALAB
JINAY PHARMACEUTICALS PRIVATE LIMITED
LABORATORIO ECZANE PHARMA S A
LABORATORIO KEMEX SA
NEXT PHARMA SOURCING S A S
ДЕРЖАВНЕ ПІДПРИЄМСТВО МЕДИЧНІ ЗАКУПІВЛІ УКРАЇНИ 01601 М КИЇВ ВУЛ ГРУШЕВСЬКОГО 7
ANALYTICA CHEMIE INC
BEACON PHARMACEUTICALS PLC
CÔNG TY TNHH DỊCH VỤ THƯƠNG MẠI PHẠM NGUYỄN
HETERO LABS LIMITED
JANSSEN CILAG FARMACEUTICA SOCIEDAD ANONIMA
KRISHNA CHEMISTS LIMITED
LABORATORIOS AC FARMA S A
PSM PHARMACEUTICALS LIMITED
ROEMMERS S A
SCORP MEDITECH LIMITED
SEVEN PHARMA SAC
SITIO SALUD S A
SUAN FARMA MEXICO SA DE CV
SUN PHARMA PHILIPPINES INC
BIOSIDUS SOCIEDAD ANONIMA
CÔNG TY TNHH KHOA HỌC HỢP NHẤT
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
DEVATIS INC
DORALBEN SA
EUROFARMA URUGUAY SOCIEDAD ANONIMA
EVEREST PHARMACEUTICALS LIMITED
F S PHARMA S A C
GENERICS AFRICA LIMITED
GLENMARK GENERICS S A
GRAMON BAGO DE URUGUAY S A
ICU VITA S A
IMSIPHARMA LIMITADA
KAIZEN PHARMACEUTICALS PVT LTD
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE LIMITED
NOVICK BIO SCIENCES PRIVATE LIMITED
PARANA MEDICAL S A
PHARMASOL PVT LTD
PROD FARMACEUTICOS MEDIPHARM L
SIGMA ALDRICH QUIMICA LTD
SUCOPEIA REFERENCESTANDARDS OPC PRIVATE LIMITED
TEXAS CANCER CENTRE LIMITED
ULTRA INTERNATIONAL
AET LABORATORIES PRIVATE LIMITED
ASCEND LABORATORIES LLC
ASOFARMA SOC ANONIMA INDUSTRIAL Y COMERCIAL
BIOMEDICAL LIFE SCIENCES
BLAUFARMA URUGUAY SA
CELNOVA ARGENTINA S A
CYGEN LABS LTDA
CÔNG TY CỔ PHẦN DƯỢC PHẨM ĐẠT VI PHÚ
CÔNG TY TNHH SẢN XUẤT NAVIS VIỆT NAM
CÔNG TY TNHH THƯƠNG MẠI DƯỢC PHẨM NAM NGUYÊN
ELCON DRUGS AND FORMULATIONS LIMITED
FARMABIOT SA DE CV
FARMAHOME S A P I DE CV
GLAXOSMITHKLINE URUGUAY S A
GLOBAL CALCIUM PRIVATE LIMITED
GOLD TREE PHARMACEUTICALS LTD
HEALTHCARE PHARMACEUTICALS LTD
ICLOS URUGUAY S A
IE MEDICA INC
INSPIRE PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LTD
JENPHAR BANGLADESH LIMITED CHANGED
JOHNSON Y JOHNSON DE URUGUAY S A
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE L
KOCAK FARMA ILAC VE KIMYA SANAYI ANONIM SIRKETI
LABORATORIO GADOR S A
MEDMART PHARMA PVT LTD
MEDSERV AFRICA LIMITED
MURRY S A
NAIROBI ENTERPRISES LIMITED
PHARMA LORD PVT LTD
PURCHASING CENTER DM UNDER THE MINISTRY OF HEALTH OF THE REPUBLIC OF UZBEKISTAN
SAKAR HEALTHCARE LIMITED
SEVEN PHARMA PANAMA
SOLUCIONES FARMACEUTICAS SOLUFARM S A
STATE INSTITUTION PURCHASING CENTER UNDER THE MINISTRY OF HEALTH OF THE REPUBLIC OF UZBEKISTAN
STATE PHARMACEUTICALS CORPORARION
TARO PHARMACEUTICALS INC
ТОО AVCARE LTD АВКЕЙР ЛТД
ALFAGEN LABORATUVAR MALZEMELERI IC VE DIS TICARET SANAYI LIMITED SIRKETI
ALLIANZ BIOINNOVATION
AMAROX PHARMA S A DE C V
AMNEAL PHARMACEUTICALS PRIVATE LIMITED
AUROBINDO PHARMA COLOMBIA S A S
AZELIS TR KIMYA ENDUSTRISI URUNLERI ITHALAT IHRACAT TICARET VE SANAYI ANONIM SIRKETI
BELMEDPREPARATY RUE
BI BIOTECH INDIA PRIVATE LIMITED
BIO TECH PHARMA SOCIEDAD ANONIMA
BIOGENE INDIA
BIONIFY BIOSCIENCE OPC PRIVATE LIMITED
BIOPROFARMA SA
BURNY S A
CHERES CATARRIVAS ISIDORO
CÔNG TY CỔ PHẦN DƯỢC PHẨM RELIV
CÔNG TY TNHH SMART INGREDIENTS
CÔNG TY TRÁCH NHIỆM HỮU HẠN SINH DƯỢC PHẨM HERA
DOM FARMACEUTICA SA DE CV
DRUG INTERNATIONAL LIMITED
EQPAL LIMITED
EVERON LIFE SCIENCES
EXPEDITORS CHARLOTTE
EXTROVIS PRIVATE LIMITED
FARMABION DEL PERU S A C
HELLMANN WORLDWIDE LOGISTICS INC
HELM DE MEXICO SA
ICLOS URUGUAY
INTERLAB LABORATUAR URUNLERI SANAYI VE TICARET ANONIM SIRKETI
JOINT CLINICAL RESEARCH CENTRE LIMITED
KHAIRI S A
KROSGEN BIYOTEKNOLOJI ARASTIRMA GELISTIRME SANAYI VE TICARET LIMITED SIRKETI
KUEHNE NAGEL A E
KUEHNE NAGEL SP Z O O
LECEX SOLUCOES LOGISTICAS LTDA
LIFE TECHNOLOGIES INDIA PRIVATE LIMITED
LIONEL MENDOZA
M S J K ENTERPRISES
M S PHARMASOL PVT LTD
M S ROTEX PHARMA PVT LIMITED
MEDICAMEN BIOTECH LIMITED
MEGA LABS SOCIEDAD ANONIMA
MEGALABS URUGUAY S A
MERCK LIFE SCIENCE LLC
MICROSULES ARGENTINA S A DE SERVICIOS COM IND INMB AGROPECUA
NOLVER S A
NOREPLEY S A
NOVECY PHARMACY CC
NOVECY PHARMACY CC NP O BOX
PHARMA INFOTECH INTERNATIONAL
PHARMAFFILIATES PRIVATE LIMITED
PHARMASOL PRIVATE LIMITED
PRODUCTOS ROCHE S A QUIMICA E INDUSTRIAL
PROVEEDORA QUIMICO FARMACEUTICA SA DE CV
QUANTIQA BARION LTDA
RAVEL CA
RENATA PLC CHANGED FROM RENATA
REVIVE HEALTH CARE
RIPPLE PHARMACEUTICALS LIMITED
RISING PHARMA HOLDINGS INC
ROTEX PHARMA PVT LTD
SCORPIO SOLUTIONS LIMITED
SHILPA MEDICARE LIMITED
SIMSON PHARMA LIMITED
SUN PHARMA DE MEXICO SA DE CV
TECHNO DRUGS LTD
THERDOSE PHARMA PRIVATE LIMITED
TOPCLASS ENTERPRISES LLP
TUTEUR SOCIEDAD ANONIMA
UGANDA CANCER INSTITUTE
URUFARMA S A
VDR DE MEXICO DISTRIBUCION SA DE CV
YUSEN LOGISTICS BENELUX BELGIUM
ТОО DPB NEW BRANDS
ТОО АДВЕНА
ТОО Р ФАРМ КАЗАХСТАН
ТОО СК ФАРМАЦИЯ
Conclusion
The temozolomide global buyers list presented here — derived from verified Indian Customs (DGFT) data — offers a clear window into a $23.5 million pharmaceutical trade ecosystem spanning 250+ buyers across 90+ countries. Whether you are a supplier seeking to expand your export footprint or a buyer looking to optimize your procurement strategy, understanding the market dynamics, key players, and regional concentrations is the first step toward success.
With the global temozolomide market projected to reach $2.44 billion by 2033, the opportunities for strategic partnerships and market expansion have never been greater.
